Evaluating Telemonitoring to Improve Adaptation to Home Mechanical Ventilation in Patients with Chronic Hypercapnic Respiratory Failure

What this Trial Is About

Researchers are evaluating whether adding telemonitoring to the usual adaptation process for home mechanical ventilation HMV helps correct hypoventilation more efficiently in patients with chronic hypercapnic respiratory failure. The study includes 48 patients eligible for HMV who do not require life support. The goal is to compare the effectiveness of telemonitoring versus standard care in reducing high carbon dioxide levels in the blood, as well as treatment adherence, unplanned visits, and hospital admissions. Participants will be randomly assigned to one of two groups a telemonitoring group or a control group. The telemonitoring group will have their HMV data reviewed daily for the first two weeks, then weekly up to six months, with phone contact and timely therapy adjustments. The control group will receive standard in-person follow-up visits at 2 weeks, 1, 2, 4, and 6 months after starting HMV, with clinical assessments and therapy adjustments. Both groups undergo similar clinical and gasometric controls, nocturnal pulse oximetry, questionnaires, and ventilator data downloads. During the study, participants will attend scheduled follow-up visits to monitor their respiratory status and ventilator use. Researchers will measure arterial blood carbon dioxide pCO2 levels at six months as the primary outcome. Secondary outcomes include treatment adherence, unforeseen visits, and hospital admissions over six months. The study aims to provide insight into the benefits of telemonitoring for patients adjusting to home mechanical ventilation.

Telemonitoring Utility in the Process of Adaptation to Home Mechanical Ventilation (HMV)